A study published in Nature Communications has uncovered the mechanisms behind two types of compounds that could help fight Alzheimer's disease. Researchers are testing the two compounds to target gamma secretase, the enzyme that cuts longer proteins into components including the form of amyloid peptide that aggregates into toxic plaques. The latest research helps explain how the new compounds interact with gamma secretase.

Full Story:

Related Summaries